Keywords: FoxO; Cancer metabolism; Tumor suppression; mTOR; Myc;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Choroid plexus carcinoma; Mouse model; Myc; Trp53; Otx2; Paediatric cancer;
Keywords: Double-hit lymphoma; High grade lymphoma; Diffuse large B-cell lymphoma; MYC; BCL2; BCL6;
Keywords: Double-expressor lymphoma; Allogeneic transplantation; Outcome; Diffuse large B-cell lymphoma; MYC; BCL2;
Keywords: Double-hit lymphoma; Double-expressor lymphoma; Diffuse large B cell lymphoma; MYC; Allogeneic;
Keywords: Purple wheat; Anthocyanin; Structural genes; MYB; MYC;
Keywords: ASO; antisense oligonucleotides; BANCR; BRAF-activated non-coding RNA; CCAT1-L; colorectal cancer associated transcript 1-long isoform; cET; constrained EThyl; EMT; epithelial to mesenchymal transition; ERV; endogenous retroviral sequence; FDA; food and d
Keywords: 5-HT; serotonin (5-hydroxytryptamine); A83-01; TGF-β kinase/activin receptor-like kinase inhibitor; ACTB; actin beta/beta-actin; ASCL1; achaete-scute homolog 1 (MASH1); ASOs; anti-sense oligonucleotides; Bcl-xL; b-cell lymphoma-extra large; BDNF; brain d
Keywords: 6-OHDA; 6-hydroxydopamine; Aβ; amyloid-β; AD; Alzheimer disease; ALS; amyotrophic lateral sclerosis; APOE4; apolipoprotein E4; APP; amyloid precursor protein; ASCL1; achaete-scute family basic helix-loop-helix transcription factor 1; ATP; adenosine trip
Keywords: FICTION; MYC; TRAIL-R1; TRAIL-R2; genetic changes
Keywords: Angiosarcoma; Dacron graft; Joint prosthesis; Joint replacement; Metal; Foreign body; MYC
Keywords: Telomerase; TERT; Cancer stemness; CSCs; Positive feedback loops; Targeted anticancer therapy; ABC; ATP-binding cassette; Akt; protein kinase B; ALDH1; aldehyde dehydrogenase 1; BAX; BCL-2-associated protein X; BCL; B-cell lymphoma family protein; BMI-1;
Keywords: myrAKT; myristoylated AKT1; AKT/RAS; myrAKT and NRAS; HCC; hepatocellular carcinoma; PBS; phosphate-buffered saline; H&E; hematoxylin and eosin; I.P.; intraperitoneal; dpi; days post-injection; mAB; monoclonal antibody; Oncogenes; MYC; AKT; RAS; Tumor; In
Keywords: Double-hit lymphomas; Double-expressing lymphomas; High grade B-cell lymphoma; MYC; BCL2;
Keywords: Kras; Myc; Smad4; Notch; IPMN; intraductal papillary mucinous neoplasm; MSI; microsatellite instability; PARP; poly-ADP-ribose polymerase; PDA; pancreatic ductal adenocarcinoma; PI3K; phosphoinositide 3-kinase inhibitor; TGF; transforming growth factor;
Keywords: Anti-cancer therapies; Cancer attractors; Cancer stem cells; Hypoxia; Inflammation; Interactome; Metabolic modeling; Networks; Senescence; Signaling; AKT; RAC-alpha serine/threonine protein kinase; BMI1; polycomb ring finger oncogene; C/EBP; CCAAT/enhance
Keywords: Myc; Protein-protein interaction; Protein structure; Transcriptional regulation; Post-translational modification; Cancer;
Keywords: 2DG; 2-deoxy-glucose; 6-AN; aminocicotinamide; ABC; ATP-binding cassette transporter; CSCs; cancer stem cells; DCA; dichloroacetate; G6PD; glucose-6-phosphate dehydrogenase; GLUT; glucose transporter; HIF; hypoxia-inducible factors; HK2; hexokinase 2; Kra
Keywords: TFs; transcription factors; GEO; Gene Expression Omnibus; FFA; free fatty acid; T2D; type 2 diabetes; IFG; impaired fasting glycemia; IGT; impaired glucose tolerance; CVD; cardiovascular diseases; HI clamp; hyperinsulinemic euglycemic clamp; SSPG; steady
Keywords: Small cell lung cancer; SCLC; CD24; CD56; Myc;
Keywords: AD; anaerobic digester; AS; activated sludge; FISH; fluorescence in situ hybridization; FOG; fats, oils, grease; HRT; hydraulic retention time; MGD; million gallons per day; MPA; Microthrix parvicella (probe); MYC; Mycolata (probe); ND; north digester; OL
Keywords: elastolysis; elastophagocytosis; AEGCG; annular elastolytic giant cell granuloma; GA; granuloma annulare; GMF; granulomatous mycosis fungoides; GSS; granulomatous slack skin; IGD; interstitial granulomatous dermatitis; MDE; mid-dermal elastolysis; MF; myc
Keywords: BRAF; B-Raf protein; BRD4; bromodomain-containing protein 4; CDK6; cyclin-dependent kinase 6; ERBB1; epidermal growth factor receptor; ERG; ETS-family oncogenic transcription factor; ERK; extracellular signal regulated protein kinase; FOS; FBJ murine oste
Keywords: AHTUS; American Heritage Time Use Study; CVD; cardiovascular disease; FAO/WHO/UNU; Food and Agriculture Organization of the United Nations, World Health Organization, and United Nations University; MET; metabolic equivalent tasks; MOC; mothers with older
Keywords: AP-1; adaptor protein 1; ASL; airway surface liquid; CCO; cytochrome c oxidase; CF; cystic fibrosis; COX-2; cyclooxygenase 2; Csk; c-src kinase; DMEM; Dulbeccos' minimal essential medium; DMT1; divalent metal ion transporter 1; DUOX; dual oxidase; EGFR;
Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients
Keywords: Glioma; Myc; The Cancer Genome Atlas;
Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody
Keywords: ANOVA; analysis of variance; BrdU; 5-bromo-2â²-deoxyuridine; CDKN1A; cyclin-dependent kinase inhibitor 1A; CDKN2A; CDKN inhibitor 2A; CE; coefficient of error; CV; coefficient of variation; D; day; E2F1; E2F transcription factor 1; FOXM1; Forkhead box pr
Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth
Keywords: LncRNA; Lnc-EPIC1; Cholangiocarcinoma (CCA); MYC;
Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer
Keywords: Canine; Homeobox gene; Prostatic cancer; MYC;
PIM activity in tumours: A key node of therapy resistance
Keywords: Prostate; Breast; Cancer; PIM; MYC; AKT; mTOR; mRNA translation;
MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells
Keywords: CTL; cytotoxic T lymphocytes; EGFR; epidermal growth factor receptor; FACS; fluorescence-activated cell sorting; HCC; hepatocellular carcinomas; Inr; initiator; PD-1; programmed cell death protein-1; PD-L1; programmed cell death-ligand; T-ALL; T cell acut
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Keywords: CIP2A; SET; PME-1; MAPK; JAK2; ERK; PPP2R1A; PPP2R2A; PPP2R5A; PPP2R5C; MYC; TP53; E2F1; AKT; Feedback;
LncRNA EPIC1 protects human osteoblasts from dexamethasone-induced cell death
Keywords: LncRNA; EPIC1; Osteoblasts; Dexamethasone; Myc;
Re-evaluating the role of FOXOs in cancer
Keywords: RTK; receptor tyrosine kinase; GF; growth factor; PI3K; Phosphatidylinositol-4,5-bisphosphate 3-kinase; PKB; protein kinase B; AKT; RAC-alpha serine/threonine-protein kinase; FOXO; forkhead box O; GFR; growth factor receptor; PDPK1; Phosphoinositide-depen
Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells
Keywords: ER; estrogen receptor; miRNAs; microRNAs; QRT-PCR; quantitative real-time polymerase chain reaction; Ct; threshold cycle; DEGs; differentially expressed genes; DEMs; differentially expressed miRNAs; PPI; protein-protein interaction; GEO; Gene Expression O
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Keywords: 9G8; serine and arginine rich splicing factor 7; AKT; AKT serine/threonine kinase; AR; androgen receptor; ARE; androgen response element; ARG1; arginase 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and rad3-related protein; BMDC; mous
The EGF/Ras pathway controls growth in Drosophila via ribosomal RNA synthesis
Keywords: Ras; ERK; Cell proliferation; Ribosome synthesis; rRNA synthesis; RNA Polymerase I; TIF-IA; Myc; Drosophila;
Identification and characterization of MYC transcription factors in Taxus sp.
Keywords: MYC; myelocytomatosis; TFs; transcription factor(s); JA; jasmonic acid; MeJA; methyl jasmonate; bHLH; basic helix-loop-helix; COR; coronatine; bHLH-Z; bHLH-zipper structure; JAZ; JASMONATE ZIM-DOMAIN proteins; PEG; Polyethylene glycol; ORF; open readi
PDK1: At the crossroad of cancer signaling pathways
Keywords: PDPK1; PI3K/Akt; Ras/MAPK; Myc; Tumor microenvironment;
Generating a recombinant phosphothreonine-binding domain for a phosphopeptide of the human transcription factor, c-Myc
Keywords: CaMKII; calmodulin-dependent protein kinase II; CDK; cyclin-dependent kinase; ERK; extracellular signal-regulated kinase; FBXW7; F-box/WD repeat containing protein 7; FN3; fibronectin type III domain; FHA1; forkhead-associated 1 domain; GSK3β; glycogen s
ER stress and cancer: The FOXO forkhead transcription factor link
Keywords: Endoplasmic reticulum; ER stress; Cancer; FOXO; Forkhead transcription factors; Unfolded protein response; AKT; Protein Kinase B; AKT1; Protein Kinase B Alpha; AMPK; AMP-activated protein kinase; ASK1; Apoptosis Signal Regulated Kinase 1; ATF4; Activating
Is Myc an Important Biomarker? Myc Expression in Immune Disorders and Cancer
Keywords: Myc; Immune disorders; Hematopoietic stem cell transplantation; Carcinomas; Hematological malignancies;
Mechanism of N6-methyladenosine modification and its emerging role in cancer
Keywords: ADAR; adenosine deaminase, RNA specific; α-KG; α-ketoglutarate; ALKBH5; alkB homologue 5; AML; acute myeloid leukemia; CDS; coding sequences; CLIP; cross-linking and immunoprecipitation; eIF3; eukaryotic initiation factor 3; ESC; embryonic stem cell; FO
Role of MSC-derived galectin 3 in the AML microenvironment
Keywords: Galectin 3; Tumor microenvironment; Acute myeloid leukemia; Reverse phase protein analysis; MYC; Integrin beta 3;
Sulfoximines as ATR inhibitors: Analogs of VE-821
Keywords: Sulfoximine; ATR inhibition; DNA repair; VE-821; Oncogene; MYC; Replication; Stress;
MYC expression correlates with PD-L1 expression in non-small cell lung cancer
Keywords: Immune checkpoint inhibitors; Myc; Non-small cell lung cancer (NSCLC); PD-L1;
Short CommunicationThe novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma
Keywords: Double-hit lymphoma; MYC; BCL2A1; anti-apoptotic protein; long-distance inverse PCR;
Original contributionB-cell posttransplant lymphoproliferative disorder isolated to the central nervous system is Epstein-Barr virus positive and lacks p53 and Myc expression by immunohistochemistry
Keywords: Posttransplant lymphoproliferative disorder; PTLD; Central nervous system lymphoma; p53; Myc;
Adenovirus E1A TRRAP-targeting domain-mediated enhancement of MYC association with the NuA4 complex activates a panel of MYC target genes enriched for gene expression and ribosome biogenesis
Keywords: E1A 1-80; MYC; ET-MYC; NuA4; TRRAP; RNA-seq;
Reviewp53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hell
Keywords: p53 Pathway; MYC; ATM; ARF; MDM2; Survival; B-cell malignancies; Myeloma; Lymphoma;